Program Overview Faculty CE Credit Fees Goals & Target Audience Learning Objectives & Program Faculty Disclosures Board Certification FAQs Financial Support

Course Expires November 30, 2011
HOPA and ASHP members, please call (913) 492-3311 to receive the member discount.

ACCP will stop taking orders for this product on November 18.

The Board of Pharmacy Specialties (BPS) has approved the Oncology Pharmacy Home Study Syllabus as one of three components in a professional development program that can be used by Board Certified Oncology Pharmacists (BCOPs) as an alternative to the written recertification examination. The Home Study Syllabus consists of a collection of journal articles that focuses on advances across the four domains of oncology specialty practice.

Topics include:

• Breast Cancer
• Central Nervous System Malignancies
• Colon Cancer
• Disease Related-Symptoms
• Gynecologic Oncology
• Hematopoietic Stem Cell Transplantation
• Literature Evaluation and Biostatistics in Oncology
• Lung Cancer
• Melanoma
• Multiple Myeloma
• Pancreatic, Stomach, and Liver Tumors
• Pediatric Oncology
• Prostate Cancer
• Supportive Care

The Oncology Pharmacy Home Study Syllabus includes a Web-based recertification test. BCOPs who read each article included in the Home Study Syllabus and successfully complete the Web-based post test on the content of the articles will earn 15.0 hours of oncology recertification credit. Please note that the series must be completed in its entirety. Partial recertification credit is not available.

The post test must be submitted by November 30, 2011 to be eligible for recertification credit. The Home Study Syllabus is priced at $250 for members of ACCP, the American Society of Health-System Pharmacists (ASHP) and the Hematology/Oncology Pharmacy Association (HOPA) and $375 for nonmembers.

ACCP, as the official provider approved by BPS, will record and report recertification credit earned in this program directly to BPS. The professional development program for oncology recertification is offered by ACCP in conjunction with ASHP and HOPA.

	Val R. Adams, Pharm.D., FCCP, BCOP Associate Professor of Pharmacy Practice and Science University of Kentucky College of Pharmacy Lexington, Kentucky
	Chad Barnett, Pharm.D., BCOP Clinical Pharmacy Specialist, Breast Onoclogy MD Anderson Cancer Center Houston, Texas
	Christopher A. Fausel, Pharm.D., BCOP Clinical Manager, Oncology Pharmacy Indiana University Simon Cancer Center Indianapolis, Indiana
	R. Donald Harvey, III, Pharm.D.,FCCP, BCPS Assistant Professor of Hematology and Oncology Director, Phase I Unit Winship Cancer Institute Emory University Atlanta, Georgia
	Mark T. Holdsworth, Pharm.D., BCOP Associate Professor, Pharmacy and Pediatrics Area Head College of Pharmacy University of New Mexico Albuquerque, New Mexico
	Theresa A. Mays, Pharm.D., BCOP Director, Investigational Drug Department South Texas Accelerated Research Therapeutics San Antonio, Texas
	Dayna L. McCauley, Pharm.D., BCOP Oncology Pharmacist Cancer Center, State University of New York at Stony Brook Long Island, New York
	Patrick J. Medina, Pharm.D., BCOP Associate Professor University of Oklahoma, College of Pharmacy Oklahoma City, Oklahoma
	Ashley K. Morris Engemann, Pharm.D., BCOP Clinical Associate Division of Cellular Therapy Duke University Medical Center Durham, North Carolina
	Dina Patel, Pharm.D., BCOP Clinical Pharmacy Specialist GI Medical Oncology MD Anderson Cancer Center Houston, Texas
	Sachin R. Shah, Pharm.D., BCOP Associate Professor of Pharmacy Practice Hemtaology/Oncology Clinical Pharmacist Texas Tech University Health Sciences Center School of Pharmacy/VANTHCS Dallas, Texas
	Linda S. Tyler, Pharm.D. Professor University of Utah Hospitals and Clinics Salt Lake City, Utah
	John Valgus, Pharm.D., BCOP Senior Clinical Specialist University of North Carolina Hospitals and Clinics UNC Eshelman School of Pharmacy

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education. This activity is approved for 15 contact hours. Universal Activity Number: 0217-9999-11-045-H01-P. This is an application-based activity.

To receive continuing pharmacy education credit, the Web-based posttest must be successfully completed and submitted to ACCP by November 30, 2011. Statements of credit for continuing pharmacy education will be available to participants through ACCP’s Web site immediately following the successful completion of the Web-based posttest.

Shipping and Handling Information

No financial support from external supporters was obtained for this course.